Metformin for Treatment of Antipsychotic-induced Dyslipidemia
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Almost all antipsychotics can induce dyslipidemia, but no treatment has been established.
Metformin can improve lipid levels in obese patients. The investigators conducted a
randomized, placebo-controlled study to test the efficacy of metformin for
antipsychotic-induced dyslipidemia.